2006
DOI: 10.1111/j.1399-3062.2006.00165.x
|View full text |Cite
|
Sign up to set email alerts
|

Antigen detection, serology, and molecular diagnosis of invasive mycoses in the immunocompromised host

Abstract: Understanding the uses and limitations of methods for rapid diagnosis of fungal disease is essential in order to diagnose and treat these infections early in their course. Antigen detection methods are useful for diagnosis of aspergillosis, cryptococcosis, histoplasmosis, blastomycosis, paracoccidioidomycosis, and penicilliosis marneffei. The accuracy of the beta-glucan assay for diagnosis of aspergillosis and candidiasis and its role in fungal diagnosis remains unclear, in part because the few published studi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
52
0

Year Published

2007
2007
2019
2019

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 86 publications
(54 citation statements)
references
References 107 publications
1
52
0
Order By: Relevance
“…It is well documented that, for patients who have been previously diagnosed with histoplasmosis, serial monitoring of Histoplasma antigen levels can be used to monitor the response to therapy, whereby significant decreases in antigen levels are commonly associated with favorable outcomes while consistently elevated or increasing antigen levels may suggest treatment failure (3,19). Also, some patients who are clinically improving may continue to In addition to our prospective study, we were able to evaluate the performance of the IMMY ASR EIA using 11 urine samples collected from patients with culture-confirmed histoplasmosis.…”
Section: Discussionmentioning
confidence: 99%
“…It is well documented that, for patients who have been previously diagnosed with histoplasmosis, serial monitoring of Histoplasma antigen levels can be used to monitor the response to therapy, whereby significant decreases in antigen levels are commonly associated with favorable outcomes while consistently elevated or increasing antigen levels may suggest treatment failure (3,19). Also, some patients who are clinically improving may continue to In addition to our prospective study, we were able to evaluate the performance of the IMMY ASR EIA using 11 urine samples collected from patients with culture-confirmed histoplasmosis.…”
Section: Discussionmentioning
confidence: 99%
“…We selected serum GMI as an outcome variable because the test is Aspergillus-specific, objective, quantitative, and shown to be an accurate measure of fungal load 9 and a validated surrogate endpoint for aspergillosis outcome. [10][11][12] We also evaluated survival because it is an important and objective clinical outcome.…”
Section: Failurementioning
confidence: 99%
“…Available diagnostic modalities for histoplasmosis include fungal culture, nucleic acid amplification tests (NAAT), histopathologic examination of tissue biopsy specimens, and Histoplasma antibody and antigen detection from body fluids. Among these methods, Histoplasma antigen detection from urine offers high clinical sensitivity for identification of patients with disseminated disease compared to alternative diagnostic methodologies (1)(2)(3). Additionally, Histoplasma antigen levels decline during disease resolution and are therefore monitored as a measure of patient response to therapy (4).…”
mentioning
confidence: 99%